Related Experiment Videos
Photopheresis in solid organ transplant rejection
Marisa B Marques1, Hande H Tuncer
1Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, 35249, USA. mmarques@path.uab.edu
Journal of Clinical Apheresis
|April 19, 2006
Summary
Photopheresis is a vital immunomodulatory treatment for conditions like T-cell lymphoma and transplant rejection. This review explores its history, benefits, and mechanisms for solid organ transplant patients.
Area of Science:
- Immunology
- Dermatology
- Transplantation Medicine
Background:
- Photopheresis is an established therapy for cutaneous T-cell lymphoma and graft-versus-host disease.
- Its application is expanding to include preventing solid organ transplant rejection.
- The historical roots of phototherapy trace back millennia, evolving into modern photopheresis.
Observation:
- This review examines the historical development of photopheresis.
- It analyzes the evidence supporting the benefits of photopheresis in solid organ transplantation.
- The mechanism of action and technical aspects of the procedure are also detailed.
Findings:
- Photopheresis demonstrates potential as a well-tolerated immunomodulatory agent.
- Preliminary data suggest efficacy in managing conditions like solid organ transplant rejection.
- Further research is warranted to fully understand its therapeutic potential.
Implications:
- Photopheresis offers a promising alternative for immunosuppression in transplant recipients.
- Understanding its mechanisms can optimize its use in various immune-related disorders.
- This review provides a comprehensive overview for clinicians and researchers.